Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nepinalone is a non-opioid antitussive agent that was historically used for the symptomatic treatment of cough. Although it was used clinically for years without a well-defined molecular target, chemoinformatics research published in 2012 identified nepinalone as a potent ligand for sigma receptors, specifically the sigma-1 and sigma-2 receptors. These receptors are known to play a role in the modulation of the cough reflex. The drug was primarily developed and marketed in Italy by Recordati under the brand name Placatus. It is currently considered a discontinued product in most major markets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nepinalone.